Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
NCT: NCT05585788 · RECRUITING
Brief Summary
This research study will evaluate the use of, and participants experience with, a new device called Addinex that safely stores and dispenses opioid medication. The purpose of this study is to evaluate the use of the Addinex device in cancer patients undergoing cancer-related surgery that require pain control with opioids after the surgery. Participants will be asked to answer questions about their medical history and background, fill out questionnaires, use a mobile application associated with the device, and undergo a phone interview one month after stopping use of the device. This study aims to find out how participants like using the Addinex device as opposed to a traditional pill bottle. Results of this study will help determine if the Addinex device could be useful to patients in the future after surgeries, as opposed to typical pill bottles.
Frequently Asked Questions
What is Opioid Dispensing Device for Post-Operative Pain in Cancer Patients?
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients is a clinical trial registered under NCT05585788. Current status: RECRUITING.
What is the status of NCT05585788?
The current status of NCT05585788 (Opioid Dispensing Device for Post-Operative Pain in Cancer Patients) is: RECRUITING.
When did Opioid Dispensing Device for Post-Operative Pain in Cancer Patients start?
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients started on 2020-10-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.